Thermo Fisher, A58117, TaqPath™ Menu ∣ GeneProof™ CT/NG/MG Multiplex PCR Kit
Quantity: 1 Kit, Unit Size: Each
Catalog Number: A58117
Send an RFQ.
Category
| Certification Compliance | CE2797 IVD / Regulation (EU) 2017/746 |
|---|---|
| Compatibility | Regularly tested by QCMD and Instand e.V. External Quality Assessment Panels |
| Control Template | PCR inhibition and DNA extraction efficiency control |
| For Use With (Equipment) | QuantStudio™ 5 Real-Time PCR System, Applied Biosystems 7500 Real-Time PCR System, AMPLilab Real-Time PCR System, AriaMx Real-Time PCR System, CFX96™/Dx Real-Time PCR Detection System, CFX Opus 96 Real-Time PCR System, croBEE Real-Time PCR System, Gentier 96E/96R Real-Time PCR System, LineGene 9600 Plus, Mic qPCR Cycler, Rotor-Gene 3000/Q |
| No. of Reactions | 100 Reactions |
| Product Line | TaqPath |
| Quantity | 1 Kit |
| Sample Type | DNA extracted from swab (cervical, urethral, vaginal), urine |
| Sensitivity | Analytical: 0.177 cp/μL (Chlamydia), 0.22 cp/μL (Neisseria gonorrhoeae), 1.129 cp/μL (Mycoplasma genitalium), Diagnostic: 100.00% (CI95%: 86.27% – 100.00%) Chlamydia trachomatis, 90.91% (CI95%: 57.12% – 99.52%) Neisseria gonorrhoeae, 100.00% (CI95%: 56.09% – 100.00%) Mycoplasma genitalium |
| Target | 16S rRNA gene and cryptic plasmid sequence for Chlamydia trachomatis, 16S rRNA gene and porA pseudogene for Neisseria gonorrhoeae, 16S rRNA gene for Mycoplasma genitalium |
Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:
Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.
| Target Specificity | 98.55% (CI95%: 95.48% – 99.62%) Chlamydia trachomatis, 98.24% (CI95%: 95.25% – 99.43%) Neisseria gonorrhoeae, 100.00% (CI95%: 96.40% – 100.00%) Mycoplasma genitalium |
|---|
| Technique | Qualitative Analysis |
|---|
| Detection Method | qPCR |
|---|
| Label or Dye | FAM |
|---|
| PCR Method | qPCR |
|---|
| Unit Size | Each |
|---|